These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
430 related items for PubMed ID: 12208768
1. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma. Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L, Gudas JM, Feng X, Bar-Eli M. Cancer Res; 2002 Sep 01; 62(17):5106-14. PubMed ID: 12208768 [Abstract] [Full Text] [Related]
3. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis. Xie S, Luca M, Huang S, Gutman M, Reich R, Johnson JP, Bar-Eli M. Cancer Res; 1997 Jun 01; 57(11):2295-303. PubMed ID: 9187135 [Abstract] [Full Text] [Related]
4. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M. Oncogene; 1997 Oct 23; 15(17):2069-75. PubMed ID: 9366524 [Abstract] [Full Text] [Related]
9. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Wu GJ, Peng Q, Fu P, Wang SW, Chiang CF, Dillehay DL, Wu MW. Gene; 2004 Mar 03; 327(2):201-13. PubMed ID: 14980717 [Abstract] [Full Text] [Related]
10. MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread. Sers C, Riethmüller G, Johnson JP. Cancer Res; 1994 Nov 01; 54(21):5689-94. PubMed ID: 7923217 [Abstract] [Full Text] [Related]
11. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis. Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M. Clin Cancer Res; 1996 Dec 01; 2(12):1969-79. PubMed ID: 9816156 [Abstract] [Full Text] [Related]
12. Molecular mechanisms of melanoma metastasis. Bar-Eli M. J Cell Physiol; 1997 Nov 01; 173(2):275-8. PubMed ID: 9365536 [Abstract] [Full Text] [Related]
14. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis. Trikha M, Zhou Z, Timar J, Raso E, Kennel M, Emmell E, Nakada MT. Cancer Res; 2002 May 15; 62(10):2824-33. PubMed ID: 12019160 [Abstract] [Full Text] [Related]
15. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Melnikova VO, Bar-Eli M. Pigment Cell Res; 2006 Oct 15; 19(5):395-405. PubMed ID: 16965268 [Abstract] [Full Text] [Related]
16. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells. Jean D, Gershenwald JE, Huang S, Luca M, Hudson MJ, Tainsky MA, Bar-Eli M. J Biol Chem; 1998 Jun 26; 273(26):16501-8. PubMed ID: 9632718 [Abstract] [Full Text] [Related]
17. Synovial fluid CD146 (MUC18), a marker for synovial membrane angiogenesis in rheumatoid arthritis. Neidhart M, Wehrli R, Brühlmann P, Michel BA, Gay RE, Gay S. Arthritis Rheum; 1999 Apr 26; 42(4):622-30. PubMed ID: 10211875 [Abstract] [Full Text] [Related]
18. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication. Satyamoorthy K, Muyrers J, Meier F, Patel D, Herlyn M. Oncogene; 2001 Aug 02; 20(34):4676-84. PubMed ID: 11498790 [Abstract] [Full Text] [Related]
19. Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro. Burrows FJ, Haskard DO, Hart IR, Marshall JF, Selkirk S, Poole S, Thorpe PE. Cancer Res; 1991 Sep 15; 51(18):4768-75. PubMed ID: 1680022 [Abstract] [Full Text] [Related]
20. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype. Bani MR, Rak J, Adachi D, Wiltshire R, Trent JM, Kerbel RS, Ben-David Y. Cancer Res; 1996 Jul 01; 56(13):3075-86. PubMed ID: 8674065 [Abstract] [Full Text] [Related] Page: [Next] [New Search]